Drug comparisons
Fremanezumab vs Diflunisal
Compare Fremanezumab (Ajovy), a CGRP monoclonal antibody for migraine prevention, with Diflunisal (Dolobid), an NSAID analgesic for pain and inflammation. Fremanezumab suits chronic migraine prophylaxis while Diflunisal treats acute pain or arthritis; selection depends on diagnosis.
No comparison dimensions are available for this page.
Clinical context
This comparison is triggered when choosing between a CGRP inhibitor for migraine prophylaxis and an NSAID for pain management or acute migraine treatment.
Bottom line
The better drug depends on the specific condition being treated, with no universal superiority between Fremanezumab and Diflunisal.
All medication comparisons